Announcements Trials

Browse Landscape

Phase

Status

Completed 23 Unknown 3 Withdrawn 1 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 6 Stomach Neoplasms 5 Melanoma 5 Carcinoma, Non-Small-Cell Lung 5 Prostatic Neoplasms 4 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Glioblastoma 4 Breast Neoplasms 4 Pancreatic Neoplasms 3 Neoplasms 3 Myelodysplastic Syndromes 3 Glioma 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Nasopharyngeal Carcinoma 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Diffuse Intrinsic Pontine Glioma 2 Warts 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thrombocythemia, Essential 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × Warts × Clear all

NCT01796795 2023-09-14

Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients

G&E Herbal Biotechnology Co., LTD

Phase 2 Suspended

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡